As a largely unregulated and anonymous channel, the Internet is rife with unauthorized distribution of prescription drugs and Active Pharmaceutical Ingredients (APIs). According to the World Health Organization over half of the drugs purchased from illicit websites are fake. Prescription drugs may be diverted, adulterated or mislabeled. Unauthorized products cost the pharmaceutical industry $200 billion per year and endanger consumer health and safety.
Every advertising dollar spent to build legitimate brands also helps fraudsters who exploit legitimate brand power to sell unauthorized or grey market drugs. Consumers are buying from illegitimate channels and increasing the threat of consumer harm and company liability.
To regain control of a complex global supply chain, reclaim lost revenue and fight this serious threat to consumer health, pharmaceutical companies must take proactive action against unauthorized online pharmacies. MarkMonitor® can help.
Our deep experience with the pharmaceutical industry has led us to develop a unique suite of technology and services to address issues arising from the proliferation of illegitimate online pharmacies. MarkMonitor not only monitors for daily online infringement and enables daily online enforcement, but also uncovers networks of suspicious pharmacies and identifies anchor sites where transactions are centrally processed. Our end-to-end solution seamlessly bridges both online and physical enforcement and enables brands to identify, target and enforce against the worst offenders.
A top-50 pharmaceutical company with dozens of leading brands in more than 140 countries combats counterfeit and grey market drug sales, domain naming abuses, consumer confusion and liability risks by using MarkMonitor Domain Management and the MarkMonitor Brand Protection™ solution.
Optimizing domains while taking action against illicit sites protects consumers, reputation and revenue.
How MarkMonitor Protects Content, Consumers and Revenue
Provides mechanisms for pharmaceutical companies to shut down unauthorized drug sales and protect revenue streams
Detects and responds to grey market selling on online pharmacies to enable better control over distribution chains
Identifies spam and fraudulent search marketing schemes which can confuse customers and lure them to illicit sites
Uncovers networks of unauthorized online pharmacies and payment anchor sites to enable focused enforcement targeting the worst offenders via online enforcement, take-down requests, physical investigation and litigation
Enables a targeted approach with custom deliverables including investigative reports, litigation support, strategic consulting and test purchase services
90% decrease in counterfeit B2B tradeboard listings, enabling the company to stop further diversion of significant revenues
200 de-listings of counterfeit bulk APIs from tradeboards, yielding a predictable, more cost-effective supply chain
67% decrease in squatted/abusive sites and the traffic they attract, resulting in higher revenues and reduced consumer confusion
Over 15,000 unnecessary domains eliminated through domain portfolio consolidation, reducing registration and management costs